• Publications
  • Influence
Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.
Bone marrow transplant recipients were found to have a 10-fold greater incidence of nosocomial Aspergillus infection than other immunocompromised patient populations (p less than 0.001) when housedExpand
  • 313
  • 11
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors.
Data from 932 patients with leukemia who received bone marrow transplants were analyzed to determine factors associated with an increased risk of developing interstitial pneumonitis. InterstitialExpand
  • 339
  • 7
Increase in circulating stem cells following chemotherapy in man.
The number of circulating granulocytic stem cells (CFU-C) was determined by the in vitro methylcellulose technique in cancer patients receiving intermittent chemotherapy. In 17 patients studied priorExpand
  • 216
  • 7
  • PDF
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.
PURPOSE A randomized clinical trial was undertaken to compare the therapeutic effectiveness of idarubicin (IDR) to daunorubicin (DNR), and both were given in combination with cytarabine (CA) in acuteExpand
  • 358
  • 6
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
T-cell depletion of donor marrow decreases graft-versus-host disease resulting from transplants from unrelated and human leukocyte antigen (HLA)-mismatched related donors. However, there are diverseExpand
  • 150
  • 4
Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.
Granulocyte-macrophage colony-stimulating activity (GM-CSA) can be produced by a variety of normal cell types including mononuclear phagocytes, activated T lymphocytes, endothelial cells, andExpand
  • 402
  • 3
  • PDF
Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer.
During a randomized trial of total parenteral nutrition (TPN) in patients with small cell lung cancer, we evaluated the short- and long-term effects of 4 weeks of TPN on nutritional assessmentExpand
  • 114
  • 3
  • PDF
Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.
Based on recently published data, IL-1 has been shown to provide radioprotective effects when given to mice 20 h before a lethal dose of irradiation and to enhance granulocyte recovery in miceExpand
  • 43
  • 3
Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission.
This study analyzed the impact of cytogenetic abnormalities on outcome of 1516 HLA-identical sibling bone marrow transplants for acute myelogenous leukemia (AML) in first remission reported to theExpand
  • 105
  • 3
Combination chemotherapy with adriamycin‐cyclophosphamide for advanced ovarian carcinoma
Combination chemotherapy with Adriamycin‐cyclophosphamide was employed after surgical treatment in 60 women with Stage III‐IV ovarian adenocarcinoma. Of 53 evaluable patients, objective response wasExpand
  • 42
  • 2